6-substituted penicillanic acid 1,1-dioxide compounds

Drug – bio-affecting and body treating compositions – Plural fermentates of different origin

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

2602452R, C07D49900, A61K 31415

Patent

active

045900736

ABSTRACT:
A series of novel derivatives of penicillanic acid 1,1-dioxide, having a disubstituted methyl group of the formula X--CH--Y at the 6-position, and the pharmaceutically-acceptable salts thereof and the pharmaceutically-acceptable esters thereof readily hydrolyzable in vivo, wherein X is hydroxy, acylated hydroxy or amino and Y is carboxy or esterified carboxy. The compounds of the invention are inhibitors of bacterial beta-lactamases, and they will protect certain beta-lactamase-susceptible beta-lactam antibiotics, e.g. ampicillin, against inactivation by beta-lactamases. Co-administration of a compound of the invention with a beta-lactam antibiotic such as ampicillin to a mammalian subject increases the effectiveness of the beta-lactam antibiotic against infections caused by beta-lactamase-producing bacteria.

REFERENCES:
patent: 4234579 (1980-11-01), Barth
patent: 4287181 (1981-09-01), Kellogg
patent: 4452796 (1984-06-01), Barth
patent: 4536393 (1985-08-01), Barth

LandOfFree

Say what you really think

Search LandOfFree.com for the USA inventors and patents. Rate them and share your experience with other people.

Rating

6-substituted penicillanic acid 1,1-dioxide compounds does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with 6-substituted penicillanic acid 1,1-dioxide compounds, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and 6-substituted penicillanic acid 1,1-dioxide compounds will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFUS-PAI-O-2108034

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.